A relative of the novel coronavirus, RaTG13, has been present in bats for the past 40 to 70 years, according to new research published in Nature Biology. The Scottish study suggests that SARS-CoV-2 has likely been poised to crossover to…
Anthony Fauci, MD, head of the National Institute of Allergy and Infectious Diseases, recently suggested that wearing eye goggles or eye shields by everyday citizens could reduce community spread of COVID-19. He noted that the eye has…
After data demonstrated Johnson and Johnson’s (J&J) one-dose vaccine offered significant protection against COVID-19 in monkeys, the pharmaceutical giant started human trials on July 30. The initial trial includes 1,000 adults in both…
New legislation, the Continuing Small Business Recovery and Paycheck Protection Program Act, has been introduced in the Senate. Under the umbrella of the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, this would…
A new treatment for individuals with leukocyte adhesion deficiency type 1 (LAD1) may also be beneficial for patients with Papillon-Lefèvre Syndrome, a genetic disorder associated with periodontitis.
Led by Regenstrief Institute research scientist Thankam Thyvalikakath, DMD, PhD, an associate professor and director of the dental informatics core at Indiana University School of Dentistry, the largest study to date of electronic dental…
An experimental investigation conducted at Kansas State University’s Biosecurity Research Institute found that SARS-CoV-2 is unable to replicate in three common types of mosquitoes, making it impossible for them to transmit the virus to…